Comparative overview of current international strategies and guidelines for genetic toxicology testing for regulatory purposes

Environmental and Molecular Mutagenesis

Volumn 47, Issue 5, 2006, Pages 362-390

  Cimino, Michael C ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Guidance; Hazard assessment; Mutagenicity; SAR; Testing battery

Indexed keywords

BACTERIAL GENE; BIOASSAY; CARCINOGENICITY; CHROMOSOME ABERRATION; GENE MUTATION; GENETIC TOXICOLOGY; GENOTOXICITY; HERITABILITY; HUMAN; MAMMAL CELL; NONHUMAN; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SCREENING TEST; STRUCTURE ACTIVITY RELATION;

GOVERNMENT REGULATION; GUIDELINES; INTERNATIONAL AGENCIES; MUTAGENICITY TESTS; MUTAGENS; RISK ASSESSMENT; UNITED STATES; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;

BACTERIA (MICROORGANISMS); MAMMALIA; RODENTIA;

EID: 33745178831     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20216     Document Type: Review

References (82)

1. Anand VP. 2000. Biocompatibility safety assessment of medical devices: PDA/ISO and Japanese guidelines. Med Device Diagnos Ind Mag Jan. 2000: 206. Available at http://www.devicelink.com/mddi/archive/ 00/01/017.html. Accessed on 15 Sept. 2005.
2. Australian Pesticides and Veterinary Medicines Authority (APVMA). 2005. Agricultural requirements series, Part 3. Toxicology. Australian Department of Health and Ageing. Available at http://www.apvma. gov.au/guidelines/ requirements3ag.shtml. Accessed on 15 Sept. 2005.
3. Bentley KS, Sariff AM, Cimino MC, Auletta AE. 1994. Assessing the risk of heritable gene mutation in mammals: Drosophila sex-linked recessive lethal test and tests measuring DNA damage and repair in mammalian germ cells. Environ Mol Mutagen 23:3-11.
4. Brusick D. 1987. Principles of Genetic Toxicology. New York: Plenum.
5. Bundesinstitut fur Risikobewertung (BfR). 2002a. Strategies for genotoxicity testing of substances: An overview. Part I: Text. Berlin, Germany, November 2002. Available at http://www.bfr.bund.de/cm/221/strategies_ for_genotoxicity_testing_of_substances_an_overview_part_i_text.pdf. Accessed on 15 Sept. 2005.
6. Bundesinstitut fur Risikobewertung (BfR). 2002b. Strategies for genotoxicity testing of substances: An overview, Part II: Table. Berlin, Germany, November 2002. Available at http://www.bfr.bund.de/ cm/221/ strategies_for_genotoxicity_testing_of_substances_an_overview_part_ii_table.pdf. Accessed on 15 Sept. 2005.
7. Carter CO. 1982. Contribution of gene mutations to genetic disease in humans. In: Bora CO, Douglas GR, Nestmann ER, editors. Progress in Mutation Research, Vol. 3. Amsterdam: Elsevier. pp 1-8.
8. Cimino MC. 2001. New OECD genetic toxicology guidelines and interpretation of results. In: Choy WN, editor. Genetic Toxicology and Cancer Risk Assessment. New York: Marcel Dekker. pp 223-248.
9. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC). 2004. Guidance on a strategy for the risk assessment of chemical carcinogens. Department of Health, UK. Available at http://www.dh.gov.uk/assetRoot/04/09/12/07/ 04091207.pdf. Accessed on 15 Sept. 2005.
10. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment (COM). 2000. Guidance on a strategy for testing of chemicals for mutagenicity. Department of Health, UK. Available at http://www.advisorybodies. doh.gov.uk/com/guidance.pdf. Accessed on 15 Sept. 2005.
11. Contrera JF, Jacobs A, DeGeorge JJ. 1997. Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals. Regul Toxicol Pharmacol 25:130-145.
12. Dearfield KL, Moore MM. 2005. Use of genetic toxicology information for risk assessment. Environ Mol Mutagen 46:236-245.
13. Dearfield KL, Auletta AE, Cimino MC, Moore MM. 1991. Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity. Mutat Res 258:259-283.
14. Dearfield KL, Douglas GR, Ehling UH, Moore MM, Sega GA, Brusick DJ. 1995. Acrylamide: A review of its genotoxicity and an assessment of heritable genetic risk. Mutat Res 330:71-99.
15. Dearfield KL, Cimino MC, McCarroll NE, Mauer I, Valcovic LR. 2002. Genotoxicity risk assessment: A proposed approach. Mutat Res 521:121-135.
16. Dellarco VL, Rhomberg LR. 1990. Quantification of germ-cell risk associated with the induction of heritable translocations. Banbury Rep 34:397-411.
17. DNH&W/DOE. 1988. Guidelines for the use of mutagenicity tests in the lexicological evaluation of chemicals. Environ Mol Mutagen 11:261-304.
18. Environment Canada (EC). 2005. Guidelines for the notification and testing of new substances: Chemicals and polymers. Available at http://www.ec.gc.ca/substances/nsb/download/cpg0901.pdf. Accessed on 15 Sept. 2005.
19. European Union (EU). 2003. Updated recommended strategy for testing hair dyes for their potential genotoxicity/mutagenicity/carcinogenicity. SCCNFP/0720/03 Final, 24th-25th June 2003.
20. European Union (EU). 2004. The Scientific Committee on Cosmetic Products and Non-Food Products Intended For Consumers. Recommended mutagenicity/ genotoxicity tests for the safety testing of cosmetic ingredients to be included in the Annexes to Council Directive 76/768/EEC (adopted 23 April 2004).
21. Fowle JR, Dearfield KL. 2000. Science policy council handbook: Risk characterization. EPA 100-B-00-002. U.S. Environmental Protection Agency, Washington, DC.
22. Health Canada (HC). 2004. Pest Management Regulatory Agency. Guidelines. Background-general provisions (Guideline 875.2000). Dated 08 Sept. 2004. Available at http://www.pmra-arla.gc.ca/ english/pdf/pro/pro98-04/ChapterB01-e. pdf. Accessed on 15 Sept. 2005.
23. Hook EB. 1982. Contribution of chromosome abnormalities to human morbidity and mortality and some comments upon surveillance of chromosome mutation rates. In: Bora CO, Douglas GR, Nestmann ER, editors. Progress in Mutation Research, Vol. 3. Amsterdam: Elsevier. pp 9-38.
24. International Conference on Harmonization (ICH). 1995a. Guideline for industry: Dose selection for carcinogenicity studies of pharmaceuticals. ICH SIC, March 1995. Available at http://www.fda.gov/ cder/guidance/ichslc.pdf. Accessed on 8 Feb. 2006.
25. International Conference on Harmonization (ICH). 1995b. Guideline for industry toxicokinetics: The assessment of systemic exposure in toxicity studies. ICH S3A, March 1995. Available at http:// www.fda.gov/cder/guidance/ ichs3a.pdf. Accessed on 8 Feb. 2006.
26. International Conference on Harmonization (ICH). 1996a. Guideline for industry: The need for long-term rodent carcinogenicity studies of pharmaceuticals. ICH SIA, March 1996. Available at http:// www.fda.gov/cder/ guidance/ichsla.pdf. Accessed on 30 Jan. 2006.
27. International Conference on Harmonization (ICH). 1996b. Guideline for industry. Specific aspects for regulatory genotoxicity testing of pharmaceuticals. ICH 2SA, April 1996. Available at http://www. fda.gov/cder/guidance/ichs2a.pdf. Accessed on 30 Jan. 2006.
28. International Conference on Harmonization (ICH). 1997a. Guidance for industry. Testing for carcinogenicity of pharmaceuticals. ICH SIB, July 1997. Available at http://www.fda.gov/cder/guidance/1854fnl.pdf. Accessed on 8 Feb. 2006.
29. International Conference on Harmonization (ICH). 1997b. Guideline for industry. Genotoxicity: A standard battery for genotoxicity testing of pharmaceuticals. ICH 2SB, July 1997. Available at http://www. hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/s2b_e.html. Accessed on 15 Sept. 2005.
30. International Conference on Harmonization (ICH). 1997c. Nonclinical safety studies for the conduct of human clinical trials for pharmaceuticals. ICH M3, July 1997. Available at http://www.fda.gov/ cder/guidance/1855fnl.pdf. Accessed on 8 Feb. 2006.
31. International Conference on Harmonization (ICH). 2003. Guidance for industry. Impurities in new drug substances. ICH Q3A, February 2003. Available at http://www.fda.gov/cber/gdlns/ichq3a.pdf. Accessed on 8 Feb. 2006.
32. International Organization for Standardization (ISO). 2003. Tests for genotoxicity, carcinogenicity, and reproductive toxicity. ISO 10993-3. Available at http://www.iso.org/iso/en/prods-services/Catalogue-ListPage.CatalogueList. Accessed on 15 Sept. 2005.
33. Jacobson-Kram D, Jacobs A. 2005. Use of genotoxicity data to support clinical trials or positive genetox findings on a candidate pharmaceutical or impurity - Now what? Int J Toxicol 24:129-34.
34. Jena GB, Kaul CL, Ramarao R. 2002. Genotoxicity testing, a regulatory requirement for drug discovery and development; impact of ICH guidelines. Ind J Pharmacol 34:86-99.
35. Kirkland DJ, Hayashi M, MacGregor JT, Müller M, Schechtman LM, Sofuni T. 2003. Summary of major conclusions. Mutat Res 540:123-125.
36. Kirkland DJ, Henderson L, Marzin D, Müller L, Parry JM, Speit G, Tweats DJ, Williams GM. 2005. Testing strategies in mutagenicity and genetic toxicology: An appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes. Mutat Res 588:88-105.
37. Lambert IB, Singer TM, Boucher SE, Douglas GR. 2005. Detailed review of transgenic rodent mutation assays. Mutat Res 590:1-280.
38. Lewtas J, DeMarini D, Favor J, Layton D, MacGregor JT, Ashby J, Lohman P, Haynes R, Mendelsohn M. 1994. Risk characterization strategies for genotoxic environmental agents. In: Brusick D, editor. Methods for Genetic Risk Assessment. Boca Raton, FL: Lewis. pp 125-169.
39. MacGregor JT. 1998. Transgenic animal models for mutagenesis studies: Role in mutagenesis research and regulatory testing. Environ Mol Mutagen 32:106-109.
40. MacGregor JT, Shane BS, Spalding J, Huff J. 1995. Carcinogenicity. In U.S. Congress (Office of Technology Assessment). In Screening and Testing Chemicals in Commerce. OTA-BP-ENV-166, Washington, DC: Office of Technology Assessment. pp 11-28.
41. Matthews EJ, Kruhlak NL, Cimino MC, Benz RD, Contrera JF. 2006a. An analysis of genotoxicity, reproductive and developmental toxicity, and carcinogenicity data. I. Identification of carcinogens using surrogate endpoints. Regul Toxicol Pharmacol 44:83-96.
42. Matthews EJ, Kruhlak NL, Cimino MC, Benz RD, Contrera JF. 2006b. An analysis of genotoxicity, reproductive and developmental toxicity, and carcinogenicity data. II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods. Regul Toxicol Pharmacol 44:97-110.
43. Mohrenweiser HW. 1991. Germinal mutation and human genetic disease. In: Li AP, Heflich RH, editors. Genetic Toxicology. Boca Raton, FL: CRC. pp 67-92.
44. Moore MM, Harrington-Brock K, Doerr CLK, Dearfield KL. 1989. Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt loci. Mutagen 4:394-403.
45. Müller L, Kikuchi Y, Probst G, Schechtman L, Shimada H, Sofuni T, Tweats D. 1999. ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: Evolution, reasoning and impact. Mutat Res 436:195-225.
46. Müller L, Kasper P, Schechtman L. 2001. ICH guidances on genotoxicity and carcinogenicity: Scientific background and regulatory practice. In: Choy WN, editor. Genetic Toxicology and Cancer Risk Assessment. New York: Marcel Dekker. pp 187-221.
47. Müller L, Blakey D, Dearfield KL, Galloway S, Guzzie P, Hayashi M, Kasper P, Kirkland D, MacGregor JT, Parry JM, Schechtman L, Smith A, Tanaka N, Tweats D, Yamasaki H. 2003. Strategy for genotoxicity testing and stratification of genotoxicity test results - Report on initial activities of the IWGT Expert Group. Mutat Res 540:177-181.
48. National Industrial Chemicals Notification and Assessment Scheme (NIC-NAS). 2005. NICNAS Handbook for notifiers. Australian Department of Health and Ageing. Available at http://www.nicnas.gov. au/publications/handbook/pdf/ Handbook-Jan2005.pdf. Accessed on 15 Sept. 2005.
49. National Institutes of Environmental Health Sciences (NIEHS). 1997. Validation and regulatory acceptance of toxicological test methods: A report of the ad hoc Interagency Coordinating Committee on the validation of alternative methods. NIH Publication No. 97-3981. NIEHS, Research Triangle Park, NC.
50. National Library of Medicine (NLM). 2006. GENE-TOX agent registry, online computer database-TOXNET file. National Institutes of Health, U.S. Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, U.S. Department of Health and Human Services, Bethesda MD, 20894. Available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX. Accessed on 22 Feb. 2006.
51. National Research Council (NRC). 1983. Risk assessment in the federal government: Managing the process. National Academy, Washington, DC.
52. Organisation for Economic Cooperation and Development (OECD). 1997. Introduction to the OECD guidelines on genetic toxicology testing and guidance on the selection and application of assays. Dated March 1, 1987, published in the Third Addendum to the OECD Guidelines for Testing of Chemicals, Paris, France. Available at http://www.oecd.org. Accessed on 15 Sept. 2005.
53. Organisation for Economic Cooperation and Development (OECD). 1998. Guidelines for the testing of chemicals. Organisation for Economic Cooperation and Development, Paris, France. Available at http:// www.oecd.org. Accessed on 15 Sept. 2005.
54. Organisation for Economic Cooperation and Development (OECD). 2004. Manual for investigation of HPV chemicals. Organisation for Economic Cooperation and Development, Paris, France. Available at http://www. oecd.org/document/7/0, 2340,en_2649_34379_1947463_1_1_1_1,00.html. Accessed on 15 Sept. 2005.
55. Organisation for Economic Cooperation and Development (OECD). 2005. Chemicals testing: OECD guidelines for the testing of chemicals (Sections 1-5). Organisation for Economic Cooperation and Development, Paris, France. Available at http://www.oecd.org/document/ 22/0,2340,en_2649_34377_1916054_1_1_1_1,00. html. Accessed on 15 Sept. 2005.
56. Sofuni T. 1993. Japanese guidelines for mutagenicity testing. Environ Mol Mutagen 21:2-7.
57. Therapeutic Goods Administration (TGA). 1995. Genotoxicity: Specific aspects of regulatory genotoxicity tests for pharmaceuticals. Australian Department of Health and Ageing. Available at http://www. tga.gov.au/docs/pdf/ euguide/vol3b/3bs6aen.pdf. Accessed on 15 Sept. 2005.
58. Therapeutic Goods Administration (TGA). 2004. Australian regulatory guidelines for complementary medicines (ARGCM), Part V: Policy. Australian Department of Health and Ageing. Available at http://www.tga.gov.au/consult/ 2004/argcmp5_dr.pdf. Accessed on 15 Sept. 2005.
59. U.S. Department of Transportation (DOT). 2002. Options to the use of halons for aircraft fire suppression system - 2002 update. Federal Aviation Administration DOT/FAA/AR-99/63, NTIS Publication, Springfield, VA.
60. U.S. Environmental Protection Agency (EPA). 1986. Guidelines for mutagenicity risk assessment. Fed Regist 51:34006-34012.
61. U.S. Environmental Protection Agency (EPA). 1987. Cresols: Final test standards and reporting requirements. Fed Regist 52:19082-19088.
62. U.S. Environmental Protection Agency (EPA). 1991. Pesticide assessment guidelines, subdivision F, hazard evaluation: Human and domestic animals, Series 84, Mutagenicity, Addendum 9. Office of Pesticides and Toxic Substances, Washington, DC. EPA-540/09-91-122, NTIS Publication No. PB91-158394.
63. U.S. Environmental Protection Agency (EPA). 1992. Guidelines for exposure assessment. Fed Regist 57:22888-22938.
64. U.S. Environmental Protection Agency (EPA). 1996a. Proposed test rule for hazardous air pollutants; test rule. 40 CFR Part 799. Fed Regist 61:33178-33200. Available at http://www.epa.gov/oppt/sids/overview.htm. Accessed on 15 Sept. 2005.
65. U.S. Environmental Protection Agency (EPA). 1996b. Proposed guidelines for carcinogen risk assessment. Fed Regist 6:17960-18011.
66. U.S. Environmental Protection Agency (EPA). 2005a. Chemical right-to-know initiative. Available at http://www.epa.gov/chemrtk/. Accessed on 15 Sept. 2005.
67. U.S. Environmental Protection Agency (EPA). 2005b. Final guidelines for carcinogen risk assessment. EPA/630/P-03/001F, March 2005. Available at http://www.epa.gov/cancerguidelines. Accessed on 13 February 2006.
68. U.S. Environmental Protection Agency (EPA). 2005c. OPPTS harmonized test guidelines, Series 870 health effects test guidelines. Available at http://www.epa.gov/opptsfrs/OPPTS_Harmonized/870_Health_- Effects_Test_Guidelines/index.html. Accessed on 15 Sept. 2005.
69. U.S. Environmental Protection Agency (EPA). 2005d. Public access to screening information data sets (SIDS). Available at http://www.epa.gov/oppt/ sids/overview.html. Accessed on 15 Sept. 2005.
70. U.S. Environmental Protection Agency (EPA). 2005e. Supplemental guidance for assessing cancer susceptibility from early-life exposure to carcinogens. EPA/630/P-03/003. March 2005. Available at http:// www.epa.gov/cancerguidelines. Accessed on 13 Feb. 2006.
71. U.S. Environmental Protection Agency (EPA). 2005f. TSCA 5(e) Exposure-based policy: Criteria. U.S. Environmental Protection Agency, Washington, DC. Available at http://www.epa.gov/opptintr/ newchems/expbased.htm. Accessed on 15 Sept. 2005.
72. U.S. Food and Drug Administration (FDA). 2004. Redbook 2000. Toxicological principles for the safety assessment of food ingredients. Center for Food Safety and Applied Nutrition, Available at http:// www.cfsan.fda.gov/ ~redbook/red-ivcl.html. Accessed on 15 Sept. 2005.
73. U.S. Food and Drug Administration (FDA). 2006. Guidance for industry and review staff. Recommended approaches to integration of genetic toxicology study results. Center for Drug Evaluation and Research, January 2006. Available at http://www.fda.gov/cder/guidance/ 6848fnl.pdf. Accessed on 9 Feb. 2006.
74. United States Code (USC). 1906. Federal Food And Drugs Act of 1906. Public Law 59-384. 21 U.S.C. 1-15.
75. United States Code (USC). 1972a. Federal Insecticide, Fungicide and Rodenticide Act. Public Law 92-516. 7 U.S.C. 136 et seq.
76. United States Code (USC). 1972b. Consumer Product Safety Act. Public Law 92-573. 15 U.S.C. 2017, Sec. 28.
77. United States Code (USC). 1976a. Toxic Substances Control Act. Public Law 94-469. 12 U.S.C. 2601.
78. United States Code (USC). 1976b. Solid Waste Disposal Act of 1965, as amended 1976. Public Law 94-580. 42 U.S.C. 6901 et seq.
79. United States Code (USC). 1993. NIH/National Institutes of Health Revitalization Act. Public Law 103-43. 42 U.S.C. 289.
80. United States Code (USC). 2000. ICCVAM Authorization Act of 2000 Act. Public Law 106-545. 42 U.S.C. 285.
81. VICH. 2004. International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products. Studies To Evaluate The Safety Of Residues Of Veterinary Drugs In Human Food: Genotoxicity Testing, VICH GL23 (Safety: Genotoxicity), Revision 1, May 2004 (http://vich.eudra.org/pdf/ 05_2004/GL23_st7-Rev.pdf) (url verified 1/26/06).
82. World Health Organization (WHO). 2003. Current practices and proposals for generation, assessment and accessibility of hazard data: Forum IV, 1-7 November 2003, Bangkok, Thailand. Intergovernmental Forum of Chemical Safety. Available at www.who.int/ifcs/documents/Forum/ForumIV/Meeting_docs/Working_docs/ 09w-F4Ann_en.doc.